Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies

NCT01256905 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01256905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01256905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Withdrawn
Start date
January 1, 2011
Completion date
August 8, 2011
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lewy bodies disease, parkinsons disease